Notes

1Pharmaceutical CGMPs for the 21st Century–A Risk-Based Approach Final Report; FDA, Sep. 2004.


2Guidance for Industry; Q 10 Pharmaceutical Quality Systems Q10, FDA, Apr. 2009 ICH.


3Guide to the Inspection of Quality Systems, FDA, Aug. 1999.


4Guidance for Industry: Q9 Quality Risk Management, FDA, Jun. 2006 ICH.


5Title 21 CFR 211.25, FDA, 2015.


6Katz, P., Campbell, C.: FDA 2011 Process Validation Guidance: Process Validation Revisited. J. of GxP Compliance 16(4):18–29, 2012.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 4, 2017 | Posted by in PHARMACY | Comments Off on Notes

Full access? Get Clinical Tree

Get Clinical Tree app for offline access